Pediatric Pharmaceuticals, Inc. – Trademark Portfolio
Entity Type: 03
Pediatric Pharmaceuticals, Inc. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include COLONGLIDE. The owner is based in Iselin, NJ.
120 Wood Avenue South, Suite 200
Iselin, NJ 08830
Showing of trademarks Trademarks
Trademark Classifications
Pediatric Pharmaceuticals, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Pediatric Pharmaceuticals, Inc. have?
Pediatric Pharmaceuticals, Inc. has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned, 2 cancelled.
What trademark classes does Pediatric Pharmaceuticals, Inc. file in?
Pediatric Pharmaceuticals, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Pediatric Pharmaceuticals, Inc.'s most well-known trademarks?
Pediatric Pharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as COLONGLIDE. These are among 1 currently registered trademark in the portfolio.
What is Pediatric Pharmaceuticals, Inc.'s trademark registration success rate?
Pediatric Pharmaceuticals, Inc. has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.